Selagine, Grifols agree to develop, commercialise immunoglobulin eye drops
Selagine is a spin-out company from the University of Illinois at Chicago (UIC), while Grifols is a provider of plasma-derived medicines. A biologic drug, an immunoglobulin eye drop